$NKTR NEKTAR THERAPEUTICS Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in NEKTAR THERAPEUTICS.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview


Overview of insider trading in NEKTAR THERAPEUTICS. Insider overview, share value development, latest insider transactions and email notifications about new events in NEKTAR THERAPEUTICS for free.

CIK Number: 0000906709
IRS Number: 943134940
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: NKTR
Company Address: 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO 94158
Phone number: (415) 482-5300
Former name: INHALE THERAPEUTIC SYSTEMS, date of change: 1994-03-03
Former name: INHALE THERAPEUTIC SYSTEMS INC, date of change: 1998-07-23

Nektar Therapeutics is a research-based biopharmaceutical company that focuses on discovering and developing medicines in areas of unmet medical need. Its research and development pipeline of new investigational drugs includes therapies for oncology, immunology and virology. The firm focuses on using new chemistry approaches to make medicines to treat cancer and auto-immune disease. The company was founded in 1990 and is headquartered in San Francisco, CA.

Market Capitalization: $2.01B
Prev close: $13.17
Average Daily Volume: 1,308,190
Days Low: $12.71
Year Low: $10.52
Year High: $19.98

NEKTAR THERAPEUTICS Latest Insider Transactions

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
May 19 2021NKTRNEKTAR THERAPEUTIC ...Wilson Mark AndrewSVP & General Couns ...SellS18.301,91735,08174,81076.7 K to 74.8 K (-2.50 %)
May 19 2021NKTRNEKTAR THERAPEUTIC ...NORTHCOTT JOHNSVP & Chief Commerc ...SellS18.306,085111,356207,107213.2 K to 207.1 K (-2.85 %)
May 14 2021NKTRNEKTAR THERAPEUTIC ...CHESS ROBERTDirectorOption ExerciseM13.808,000110,40024,000
May 14 2021NKTRNEKTAR THERAPEUTIC ...CHESS ROBERTDirectorSellS19.348,000154,720280,573288.6 K to 280.6 K (-2.77 %)
May 14 2021NKTRNEKTAR THERAPEUTIC ...CHESS ROBERTDirectorBuyM13.808,000110,400288,573280.6 K to 288.6 K (+2.85 %)
Apr 16 2021NKTRNEKTAR THERAPEUTIC ...CHESS ROBERTDirectorOption ExerciseM13.808,000110,40032,000
Apr 16 2021NKTRNEKTAR THERAPEUTIC ...CHESS ROBERTDirectorSellS18.988,000151,840280,573288.6 K to 280.6 K (-2.77 %)
Apr 16 2021NKTRNEKTAR THERAPEUTIC ...CHESS ROBERTDirectorBuyM13.808,000110,400288,573280.6 K to 288.6 K (+2.85 %)
Feb 18 2021NKTRNEKTAR THERAPEUTIC ...Zalevsky JonathanChief R&D OfficerSellS22.3724,141540,034266,176290.3 K to 266.2 K (-8.32 %)
Feb 18 2021NKTRNEKTAR THERAPEUTIC ...Wilson Mark AndrewSVP & General Couns ...SellS22.372,17348,61076,72778.9 K to 76.7 K (-2.75 %)
Feb 18 2021NKTRNEKTAR THERAPEUTIC ...Thomsen Jillian B.SVP & Chief Account ...SellS22.3711,705261,841164,552176.3 K to 164.6 K (-6.64 %)
Feb 18 2021NKTRNEKTAR THERAPEUTIC ...ROBIN HOWARD WPresident & CEOSellS22.3711,495257,143447,198458.7 K to 447.2 K (-2.51 %)
Feb 18 2021NKTRNEKTAR THERAPEUTIC ...NORTHCOTT JOHNSVP & Chief Commerc ...SellS22.3715,358343,558213,192228.6 K to 213.2 K (-6.72 %)
Feb 18 2021NKTRNEKTAR THERAPEUTIC ...Labrucherie Gil MSVP, COO & CFOSellS22.377,977178,445258,996267 K to 259 K (-2.99 %)
Feb 04 2021NKTRNEKTAR THERAPEUTIC ...Wilson Mark AndrewSVP & General Couns ...Option ExerciseM8.805,34447,0270

View all NEKTAR THERAPEUTICS insider transactions.